Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

ConditionsAtopic Dermatitis Eczema Atopic Dermatitis Eczema Caregiver Burden

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorPeriPharm

About this trial

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged ≥18 years;

Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis;

Able to read and understand French or English;

Willing and able to provide written informed consent.

Disqualifiers

Caregivers whose child has been diagnosed with severe atopic dermatitis ;

Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor);

Caregivers whose child is currently participating in a clinical trial for atopic dermatitis;

Other parent or caregiver within the household of the child with atopic dermatitis.

Trial population

Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

No Intervention: Observational Cohort
Other intervention
No specific intervention is assess in this study. Observational cohort.

Treatment groups

100 Participants

are divided into 1 treatment group

Group A: Caregiver of child with atopic dermatitis1 intervention

Trial outcomes

Primary outcomes

To estimate work productivity loss in caregivers of children with mild or moderate atopic dermatitis.

Using the Work Productivity and Activity Impairment questionnaire. This questionnaire provides a quantitative measure of impairment over the last 7 days and includes four metrics: absenteeism (work time missed because of health issues during the past 7 days), presenteeism (impairment while working due to health issues during the past 7 days), overall work productivity loss (combination of absenteeism and presenteeism), and activity impairment.

Time frame

At recruitment

Secondary outcomes

To estimate family burden of mild to moderate atopic dermatitis in children, as reported by caregivers

The Dermatitis Family Impact (DFI) questionnaire will be administered to caregivers to evaluate the family burden of pediatric atopic dermatitis. The DFI is a validated, 10-item instrument specifically developed for atopic dermatitis, covering domains such as housework, feeding, sleep, leisure activities, time spent shopping, expenditure, physical fatigue, emotional distress, relationships, helping with treatment, with a 7-day recall period. Each item is scored on a 4-point Likert scale ("Not at all = 0" to "Very much = 3"), with higher total scores indicating greater impact

Time frame

At recruitment

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

PeriPharm

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: